tetraethylammonium has been researched along with gamma-butyrobetaine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, D; Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A | 1 |
| Galluccio, M; Indiveri, C; Pani, G; Pochini, L; Scalise, M; Siminovitch, KA | 1 |
2 other study(ies) available for tetraethylammonium and gamma-butyrobetaine
| Article | Year |
|---|---|
Molecular and functional characterization of organic cation/carnitine transporter family in mice.
Topics: Amino Acid Sequence; Animals; Base Sequence; Carrier Proteins; Cell Line; DNA, Complementary; Humans; Membrane Proteins; Membrane Transport Proteins; Mice; Molecular Sequence Data; Organic Cation Transport Proteins; Recombinant Proteins; Sequence Homology, Amino Acid; Symporters | 2000 |
The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease.
Topics: Acetylcarnitine; Acetylcholine; Adenosine Triphosphate; Amino Acid Substitution; Betaine; Biological Transport, Active; Carnitine; Catalysis; Crohn Disease; Humans; Kinetics; Liposomes; Mutation, Missense; Nootropic Agents; Organic Cation Transport Proteins; Potassium Channel Blockers; Symporters; Tetraethylammonium | 2012 |